JAK-STAT signaling pathway inhibition: a role for treatment of discoid lupus erythematosus and dermatomyositis

A case of refractory dermatomyositis responsive to tofacitinib

(2017) Julie J. Paik et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis

(2017) Naoki Iwamoto et al.   PLoS One

Microarray study reveals a transforming growth factor-β-dependent mechanism of fibrosis in discoid lupus erythematosus

(2016) C. Solé et al.   BRITISH JOURNAL OF DERMATOLOGY

JAK1/2 Inhibitor Ruxolitinib Controls a Case of Chilblain Lupus Erythematosus

(2016) Joerg Wenzel et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Cytokines and Effector/Regulatory Cells Characterization in the Physiopathology of Cutaneous Lupus Erythematous: A Cross-Sectional Study

(2016) Silvia Méndez-Flores et al.   MEDIATORS OF INFLAMMATION

Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction

(2016) Yasuko Furumoto et al.   Arthritis & Rheumatology

The role of type I interferons and other cytokines in dermatomyositis

(2015) Ashish Arshanapalli et al.   CYTOKINE

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

(2015) S. Verstovsek et al.   HAEMATOLOGICA

Ruxolitinib Attenuates Cutaneous Lupus Development in a Mouse Lupus Model

(2015) Emilie S. Chan et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Pathophysiology of cutaneous lupus erythematosus

(2015) Jordan C Achtman et al.   ARTHRITIS RESEARCH & THERAPY

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

(2015) S. Verstovsek et al.   HAEMATOLOGICA

Remission of Recalcitrant Dermatomyositis Treated with Ruxolitinib

(2014) Thorsten Hornung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dominant Th1 and Minimal Th17 Skewing in Discoid Lupus Revealed by Transcriptomic Comparison with Psoriasis

(2013) Ali Jabbari et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score

(2012) I. Braunstein et al.   BRITISH JOURNAL OF DERMATOLOGY

Clinical presentation and evaluation of dermatomyositis

(2012) DavidF Fiorentino et al.   INDIAN JOURNAL OF DERMATOLOGY

Interferon-α stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus

(2011) S. Zahn et al.   BRITISH JOURNAL OF DERMATOLOGY

Interferon-α in the generation of monocyte-derived dendritic cells: recent advances and implications for dermatology

(2011) Á. Farkas et al.   BRITISH JOURNAL OF DERMATOLOGY

Quality of life in cutaneous lupus erythematosus

(2011) Rachel Klein et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Type I interferon pathway in adult and juvenile dermatomyositis

(2011) Emily C Baechler et al.   ARTHRITIS RESEARCH & THERAPY

Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon production

(2010) Anne P. Liao et al.   CLINICAL IMMUNOLOGY

Incidence of Cutaneous Lupus Erythematosus, 1965-2005

(2009) Olayemi Durosaro et al.   ARCHIVES OF DERMATOLOGY

Activation of the interferon-γ signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells

(2009) Thomas Karonitsch et al.   ARTHRITIS AND RHEUMATISM

Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage

(2009) William Vermi et al.   IMMUNOBIOLOGY

Clinical Characteristics and Outcomes of Juvenile and Adult Dermatomyositis

(2009) Sang-Jun Na et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Early Diagnosis and Treatment of Discoid Lupus Erythematosus

(2009) S. Panjwani   Journal of the American Board of Family Medicine